Press Releases

Apr 09, 2021 5:00am EDT

Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-up

Mar 23, 2021 6:00am EDT

Greenwich LifeSciences CEO to Participate on Cancer Panel and to Present at Benzinga Biotech Conference

Mar 11, 2021 6:00am EST

Greenwich LifeSciences Updates 2021 Timeline & Announces Two Upcoming Presentations at the American Association for Cancer Research Annual Meeting

Mar 10, 2021 7:59pm EST

Greenwich LifeSciences CEO to be Interviewed Live on Benzinga’s Power Hour

Mar 08, 2021 6:00am EST

Greenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to Manage Phase III Clinical Trial for Recurring Breast Cancer

Mar 02, 2021 6:00am EST

Greenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring Conferences

Feb 25, 2021 6:00am EST

Greenwich LifeSciences Announces Acceptance of Two Abstracts at Upcoming Major Cancer Conference

Jan 29, 2021 11:33am EST

Greenwich LifeSciences Announces Exercise and Closing of Underwriter’s Over-Allotment Option

Jan 29, 2021 6:00am EST

Greenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money Report

Jan 21, 2021 6:00am EST

Greenwich LifeSciences to Present at B. Riley Securities and BIO CEO & Investor Conferences